Latest News about AZN
Recent news which mentions AZN
   Royal Rule: Buy These 3 Dividend Aristocrats on Every. Single. Dip.
   
  
  
  November 13, 2023
  From InvestorPlace
 
   Investigating AstraZeneca's Standing In Pharmaceuticals Industry Compared To Competitors
   
  November 13, 2023
  Tickers 
   AZN
  
  
  From Benzinga
 
   Who’s afraid of Ozempic? From restaurants to package makers, companies work to calm investors’ GLP-1 jitters.
   
  
  
  November 10, 2023
  From MarketWatch
 Tags
   COST
   Market News
   NASDAQ:AAPL,NYSE:LMT,NYSE:CVX,NASDAQ:LI,NYSE:CRM,NASDAQ:AZN,NASDAQ:COST,NYSE:RIO
  
  From InvestorPlace
 
   AstraZeneca Plc (AZN) Q3 2023 Earnings Call Transcript
   
  November 09, 2023
  Tickers 
   AZN
  
  
  From Motley Fool
 
   AstraZeneca Joins Anti-Obesity Race Dominated By Eli Lilly And Novo Nordisk, Reports Mixed Q3 Earnings
   
  November 09, 2023
  Tickers 
   AZN
  
  
  From Benzinga
 
   Wall Street To Snap Longest Winning Streak Since 2021 Today? Earnings, Bond Yields In Focus Ahead Of Powell's Speech
   
  
  
  November 09, 2023
  From Benzinga
 
   Virgin Galactic shares surge as space firm doubles revenue while Walt Disney stock jumps on spike in streaming customers
   
  
  
  November 09, 2023
  From MarketWatch
 
   AstraZeneca hikes earnings forecast as surging cancer drug sales offset plunging revenue from COVID vaccines
   
  November 09, 2023
  Tickers 
   AZN
  
  
  From MarketWatch
 
   The doctor lowering drug prices for 1 million patients, with help from Mark Cuban, Sam Altman – and Martin Shkreli
   
  
  
  November 06, 2023
  From MarketWatch
 
   7 Evergreen Stocks for Long-term Wealth Generation
   
  
  November 03, 2023
  Tags
   NYSE:CVX,NASDAQ:AZN,NYSE:LMT,NASDAQ:TSLA,NASDAQ:AAPL,NYSE:NEM,NASDAQ:COST,OTCMKTS:NCMGF
   TSLA
   AZN
  
  From InvestorPlace
 
   Why Is Cancer Player Cellectis Stock Trading Over 100% Higher Today?
   
  
  
  November 01, 2023
  From Benzinga
 
   Why Is Cellectis (CLLS) Stock Up 175% Today?
   
  
  
  November 01, 2023
  From InvestorPlace
 From InvestorPlace
 
   Comparative Study: AstraZeneca And Industry Competitors In Pharmaceuticals Industry
   
  October 30, 2023
  Tickers 
   AZN
  
  
  From Benzinga
 
   3 No-Brainer Stocks to Buy for Under $100 Right Now
   
  
  
  October 28, 2023
  From Motley Fool
 From MarketWatch
 
   Stocks to own ahead of a rally that this $15 billion fund house says is coming soon
   
  
  
  October 25, 2023
  From MarketWatch
 
   Why Is LumiraDx (LMDX) Stock Down 35% Today?
   
  
  
  October 24, 2023
  From InvestorPlace
 
   10 Health Care Stocks With Whale Alerts In Today's Session
   
  
  
  October 23, 2023
  From Benzinga
 
   Why Is LumiraDx (LMDX) Stock Up 323% Today?
   
  
  
  October 23, 2023
  From InvestorPlace
 
   Merck Signs Multi-Billion Deal With Japan's Daiichi Sankyo For Cancer Therapy Drug Development
   
  
  
  October 20, 2023
  From Benzinga
 
   United Airlines, Interactive Brokers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
   
  
  
  October 18, 2023
  From Benzinga
 
   FDA Approves Merck's Top Selling Drug, Keytruda For Expanded Use In Lung Cancer Indication
   
  
  
  October 17, 2023
  From Benzinga
 
   Pfizer, Sanofi's Respiratory Syncytial Virus Products Faces Insurance And Logistical Hurdles To Protect Infants
   
  
  
  October 16, 2023
  From Benzinga
 
   Understanding AstraZeneca's Position In Pharmaceuticals Industry Compared To Competitors
   
  October 16, 2023
  Tickers 
   AZN
  
  
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 


